EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case–Control Study and Call for a Consensus

Anna B Szabo, Jonathan Curot, Fleur Gérard, Florence Rulquin, Rachel Debs, Claire Georges, Marie Denuelle, Amel Bouloufa, Béatrice Lemesle, Patrice Péran, Claire Thalamas, Emmanuel J Barbeau und 3 weitere

Annals of Neurology · 2026

DOI: 10.1002/ana.78135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Anna B Szabo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherches sur la Cognition Animale, Centre de Biologie Intégrative, Université de Toulouse, CNRS, Toulouse, France. Hauptthemen laut MEDLINE: Alzheimer Disease, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sleep‐predominant network hyperexcitability is increasingly recognized as a potential disease‐accelerating comorbidity in Alzheimer's disease (AD). However, its prevalence and risk‐factors remain debated, largely due to cohort‐specific and methodological differences across studies. In this prospective case‐control study, we investigated potential ways of improving detection, from translational approaches focusing on rapid eye movement (REM)‐sleep to refined electroencephalogram (EEG) setups and added clinical questionnaires.

Methods

We recruited 30 patients with early‐stage AD without a history of epilepsy and 30 age‐matched controls. Participants underwent overnight polysomnography with video‐EEG. Interictal epileptic discharges (IEDs) were identified through a structured 3‐step review by multiple independent experts using recommended criteria. Neuroanatomic patterns and sleep‐related abnormalities were investigated as potential risk factors. Clinical symptoms in favor of epileptic seizures were evaluated through a tailored questionnaire at follow‐up.

Results

IEDs were detected in 3 patients (10%) and 1 control (3.33%), a difference not reaching statistical significance ( p = 0.612). Most events occurred during non‐REM (NREM) sleep. Eight patients (26.67%) reported symptoms compatible with epileptic seizures—one of whom also presented with IEDs. Patients with IEDs or reported symptoms suggestive of potential seizures exhibited more severe sleep‐disordered breathing and reduced precuneus volume compared with those without.

Interpretation

Despite efforts to optimize detection accuracy, our findings reveal a lower‐than‐expected percentage of patients with AD with IEDs, yet support previous findings suggesting that sleep‐disordered breathing and specific atrophy patterns could flag at‐risk patients, guiding screening in clinical settings. Our findings also favor validation efforts of questionnaires to support the diagnostic process. Finally, we highlight methodological issues in IED detection and call for the re‐evaluation and standardization of diagnostic methods and criteria in this population to improve patient care. ANN NEUROL 2026;99:1046–1058

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEpilepsyHumansFemaleMaleCase-Control StudiesElectroencephalographyAgedPolysomnographyProspective StudiesAged, 80 and overSurveys and QuestionnairesMiddle AgedSleep, REM

Autor:innen und Institutionen

  • Centre de Recherches sur la Cognition Animale, Centre de Biologie Intégrative, Université de Toulouse, CNRS, Toulouse, France.
  • Brain and Cognition Research Center (CerCo), CNRS, UMR 5549, University of Toulouse, Toulouse, France.
  • Department of Neurology, Pierre Paul Riquet Hospital, Toulouse University Hospital, University of Toulouse, Toulouse, France.
  • Faculty of Health, University of Toulouse, Toulouse, France.
  • Department of Cognitive Neurology, Pierre Paul Riquet Hospital, Toulouse University Hospital, Toulouse, France.
  • Toulouse Neuroimaging Center, UMR1214, Inserm/UPS, Toulouse, France.

ORCID-Profile: Lionel Dahan

Zitieren

APA

B Szabo, A., Curot, J., Gérard, F., Rulquin, F., Debs, R., Georges, C., Denuelle, M., Bouloufa, A., Lemesle, B., Péran, P., Thalamas, C., Barbeau, E. J., Pariente, J., Dahan, L., & Valton, L. (2026). Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case–Control Study and Call for a Consensus. Annals of Neurology. https://doi.org/10.1002/ana.78135

Vancouver

B Szabo A, Curot J, Gérard F, Rulquin F, Debs R, Georges C, et al. Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case–Control Study and Call for a Consensus. Annals of Neurology. 2026. doi:10.1002/ana.78135

BibTeX
@article{BSzabo2026,
  author = {B Szabo, Anna and Curot, Jonathan and Gérard, Fleur and Rulquin, Florence and Debs, Rachel and Georges, Claire and Denuelle, Marie and Bouloufa, Amel and Lemesle, Béatrice and Péran, Patrice and Thalamas, Claire and Barbeau, Emmanuel J and Pariente, Jérémie and Dahan, Lionel and Valton, Luc},
  title = {Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A Case–Control Study and Call for a Consensus},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78135}
}
Kostenlos starten →